====== Becky Paul ======
**Becky Paul** is a researcher at **Isomorphic Labs**, the pharmaceutical artificial intelligence company and spinout of Google DeepMind. Paul's work focuses on the application of artificial intelligence and machine learning methodologies to accelerate drug discovery and molecular design processes.

===== Research Focus =====
Paul specializes in AI-driven approaches to medicine design and drug development. Her research integrates computational methods with pharmaceutical chemistry to address challenges in molecular discovery. The work conducted at Isomorphic Labs applies advanced machine learning techniques, building upon foundational research in structural biology and protein folding to identify and optimize potential therapeutic compounds (([[https://www.deepmind.com/|DeepMind - Official Site (2024]])).

===== Isomorphic Labs Context =====
Isomorphic Labs was established as a dedicated pharmaceutical research division leveraging Google DeepMind's expertise in artificial intelligence for biological systems. The organization applies machine learning to accelerate the drug discovery pipeline, reducing timelines and improving success rates in identifying viable drug candidates (([[https://www.isomorphiclabs.com/|Isomorphic Labs - Official Site (2024]])).

The laboratory represents a significant convergence of computational biology and pharmaceutical research, where AI models trained on structural and chemical data can predict molecular properties and interactions relevant to therapeutic development. This approach addresses historical bottlenecks in drug discovery where identifying and validating lead compounds traditionally required extensive experimental validation (([[https://arxiv.org/abs/2206.07179|Senior et al. "Protein structure prediction in the era of artificial intelligence" (2022]])).

===== Professional Context =====
Paul's role as a researcher at Isomorphic Labs positions her within a team working directly on practical applications of artificial intelligence to real-world pharmaceutical challenges. This work builds on foundational breakthroughs in protein structure prediction and computational chemistry, translating algorithmic advances into tangible therapeutic discovery outcomes (([[https://arxiv.org/abs/2007.15779|Jumper et al. "Highly accurate protein structure prediction with AlphaFold" (2020]])).


===== See Also =====
  * [[deepmind|DeepMind]]
  * [[google_deepmind|Google DeepMind]]
  * [[deepmind_ai_co_mathematician|DeepMind AI Co-Mathematician]]
  * [[isomorphic_labs|Isomorphic Labs]]
  * [[demis_hassabis|Demis Hassabis]]

===== References =====